Systemic mycosis due Pseudallescheria boydii in a double transplant patient with a cystic fibrosis. Study of isolated strains with RAPD (Random Amplification of Polymorphic DNA);Mycose systemique a Pseudallescheria boydii chez une patiente greffee bipulmonaire pour une mucoviscidose. Etude des souches isolees en RAPD (Random Amplification Polymorphic DNA)

Journal de Mycologie Medicale

Volumn 9, Issue 2, 1999, Pages 119-123

  Morin, O ^a,c   Haloun, A ^a   Treilhaud, M ^a   Sagan, C ^a   Boiron, P ^b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

^c INSTITUT DE BIOLOGIE   (France)

Author keywords

Cystic fibrosis; Lung transplant; Pseudallescheria boydii; RAPD; Scedosporium apiospermum; Systemic mycosis

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; ECONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE;

ABSCESS; ADULT; ARTICLE; ASCOMYCETES; ASPERGILLUS FUMIGATUS; CASE REPORT; CONSCIOUSNESS DISORDER; CYSTIC FIBROSIS; DRUG SENSITIVITY; FEVER; GRAFT REJECTION; HEADACHE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; LUNG TRANSPLANTATION; MYCOSIS; RANDOM AMPLIFIED POLYMORPHIC DNA; RESPIRATORY FAILURE;

EID: 0032819084     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Albernaz V, Huston B, Castillo M, Mukerji S, Bouldin TW. Pseudallescheria boydii infection of the brain : imaging with pathologic confirmation. AJNR 1996;17:589-92.
2. Aufauvre-Brown A, Cohen J, Holden DW. Use of random by amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus. J Clin Microbiol 1992;30:2991-3.
3. Bernal M, Baquero-Mezence MI, Provost F, Laurent F, Martinez-Machin G, Boiron P. A one step Candida albicans DNA extraction method using « chelex R 100 resin » for amplification chain reaction. J Mycol Med 1997:7:53-4.
4. Chabasse D, Bouchara JP, Chazalette JP, Carrere J, Ginies JL, de Gentile L et al. Mucoviscidose et colonisation fongique à Scedosporium apiospermum. A propos de trois observations. J Mycol Med 1991;1:152-5.
5. Cimon B, Carrere J, Chazalette JP, Ginies JL, Six P, Vinatier JF et al. Fungal colonization and immune response to fungi in cystic fibrosis. J Mycol Med 1995:5:211-6.
6. Dupont B, Improvisi L, Ronin O. Aspects épidémiologiques et cliniques des infections à Scedosporium et à Pseudallescheria. J Mycol Med 1991;118:33-42.
7. Hennequin C, Benailly N, Silly C, Sorin M, Scheinmann P, Lenoir G et al. In vitro susceptibilities to amphotericin B, itraconazole and miconazole of filamentous fungi isolated from patients with cystic fibrosis. Antimicrob Agents and Chem 1997;41:2064-6.
8. Hofman P, Saint-Paul MC, Gari-Toussaint M, Michiels JF, Boissy C, Jambou P et al. Infection disséminée à Scedosporium apiospermum chez un transplanté hépatique. Un diagnostic différentiel de l'aspergillose invasive. Ann Pathol 1993;13:332-5.
9. Lavarde V, Traoré F, Farge D, de Bièvre C, Dupont B. Un cas d'abcès cérébral dû à Scedospermum apiospermum (Pseudallescheria boydii) chez un transplanté rénal. Bull Soc Fr Mycol Med 1989;18:149-52.
10. Loudon KW, Burnie JP, Coke AP, Matthews RC. Application of polymerase chain reaction to finger printing Aspergillus fumigattus by random amplification of polymorphic DNA. J Clin Microbiol 1993;31: 1117-21.
11. Rabodonirina M, Paulus S, Thevenet F, Loire R, Guého E, Bastien O et al. Disseminated Scedosporium prolificans (S. inflatum) infection after single lung transplantation. Cl Infect Dis 1994;19:138-42.
12. Radford SA, Johnson EM, Warnock DW. In vitro studies of activity antifungal agent, against emerging and less common mold pathogens. Antimicrob Agents and Chem 1997;41:841-3.
13. Ruhel R, Wilichowski E. Cerebral Pseudallescheria mycosis after near-drowning. Mycoses 1995;38:473-5.
14. Ruiz-Diez B, Martine ZF, Rodriguez-Tuleda JL, Alvarez M, Martinez-Suarez JV. Use of random amplification of polymorphic DNA (RAPD) and PCR-finger printing for genotyping a Scedosporium prolificans (inflatum) outbreak in four leukemic patients. Cur Microb 1997;35:186-90.
15. Verweij PE, Cox NJM, Meis JFG. Oral terbinafine for treatment of pulmonary Pseudallescheria boydii infection refractory to itraconazole therapy. Eur J Clin Microbiol Infect Dis 1996;15:26-8.
16. Verweij PE, Meis JFGM, Sarfati J, Hoogkamp-Korstanje JAA, Latge JP, Melchers WJG. Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis. J Clin Microbiol 1996;34:2595-7.
17. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium of simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991;10:506-13.
18. Walsh TI, Peter J, Mc Gouch DA, Fothergill AW, Rinaldi MG, Pizzo PA. Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob Agents and Chem 1995:39:1361-4.
19. Yano S, Shishido S, Toritani T, Yoshida K, Nakano H. Intrabronchial Pseudallescheriasis in an immunocompetent woman. Cl Inf Dis 1997;24:735-6.